Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study

Authors

Keywords

Journal

Volume 18, Issue 2, Pages 230-240

Publisher

Elsevier BV

Online

2017-01-13

DOI

10.1016/s1470-2045(17)30012-8

Contact the author

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.